Wolverine Blend (10mg)

What is Wolverine Blend (BPC-157 + TB-500)?

Wolverine Blend (BPC-157 + TB-500) is a catalog research material in the recovery & repair category. The listed strengths describe total vial contents for laboratory research.

Listed vial contents: 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.

What mechanisms are being studied?

This formulation combines BPC-157, a gastric-derived pentadecapeptide studied in angiogenesis and nitric-oxide signaling models, with TB-500, a synthetic thymosin beta-4 fragment studied in actin regulation and cell migration. The blend itself has not been established as more effective than its individual components.

What are the research questions?

• Combination-pathway studies in controlled laboratory models
• Comparative research against separately prepared BPC-157 and TB-500
• Cell migration, angiogenesis, and tissue-repair signaling research

What does the published work describe?

Published evidence concerns the individual components; controlled studies of this fixed blend are limited.

What are the limits of this evidence?

The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.

Study references

1. Sikiric P et al. Curr Pharm Des. 2018;24:1972-1989
2. Goldstein AL et al. Ann N Y Acad Sci. 2012;1269:1-5

These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.

How should I check lot documentation?

Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.